Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma

NCT00379080 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Adult Brain Tumor
Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma
Recurrent Adult Brain Tumor

Interventions

PROCEDURE: conventional surgery
DRUG: tandutinib
OTHER: pharmacological study
OTHER: Tissue samples

Sponsor

National Cancer Institute (NCI)